Skip to main content
Top
Published in: Tumor Biology 11/2014

01-11-2014 | Research Article

CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies

Authors: Kai-Tao Yu, Cheng Ge, Xiao-Fang Xu, Jing-Cai Zou, Xuan Zou, Shuai Zhen

Published in: Tumor Biology | Issue 11/2014

Login to get access

Abstract

The cytochrome CYP1A1 gene has been implicated in the etiology of oral cancer. However, the results have been inconsistent. In this study, a meta-analysis was performed to clarify the associations of polymorphisms in CYP1A1 gene with oral cancer risk. Published literatures from PubMed, MEDLINE, EMBASE, and China National Knowledge infrastructure (CNKI) databases were retrieved. A total of 12 studies were included in this meta-analysis. We found that significant positive associations between CYP1A1*2A polymorphism and oral cancer risk in recessive model (CC vs. TC + TT, OR = 1.93), dominant model (CC + TC vs. TT, OR = 1.33), and additive model (CC vs. TT, OR = 1.97). In subgroup analysis based on the ethnicity of study population, significant associations were found in all three genetic models for Asians (recessive OR = 2.29, 95 % CI = 1.42–3.71; dominant OR = 1.54, 95 % CI = 1.03–2.31; additive OR = 2.39, 95 % CI = 1.47–3.88) but not non-Asians. For the smoking stratification, the result indicated a significant association between CYP1A1*2A polymorphism and oral cancer among the smoking subjects (OR = 1.83, 95 % CI = 1.47–2.26). This meta-analysis indicated a marked association of CYP1A1*2A polymorphisms with oral cancer risk, particularly among Asians, whereas there were significant interactions between the polymorphisms and cigarette smoking on oral cancer risk.
Literature
1.
go back to reference Zygogianni AG, Kyrgias G, Karakitsos P, Psyrr A, Kouvars J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.PubMedCentralPubMedCrossRef Zygogianni AG, Kyrgias G, Karakitsos P, Psyrr A, Kouvars J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.PubMedCentralPubMedCrossRef
2.
go back to reference Reichart PA, Nguyen XH. Betel qud chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008;37:511–4.PubMedCrossRef Reichart PA, Nguyen XH. Betel qud chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008;37:511–4.PubMedCrossRef
3.
go back to reference Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev. 2000;9:1119–22.PubMed Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev. 2000;9:1119–22.PubMed
4.
go back to reference Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201–13.PubMedCrossRef Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201–13.PubMedCrossRef
5.
go back to reference Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161:901–15.PubMedCrossRef Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161:901–15.PubMedCrossRef
6.
go back to reference Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Genet. 1991;48:720–5. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Genet. 1991;48:720–5.
7.
go back to reference Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35:191–6.PubMedCrossRef Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35:191–6.PubMedCrossRef
8.
go back to reference Balaji L, Singh KB, Bhaskar LV. CYP1A1 genotypes and haplotypes and risk of oral cancer: a case-control study in South Indians. Genet Mol Biol. 2012;35(2):407–12.PubMedCentralPubMedCrossRef Balaji L, Singh KB, Bhaskar LV. CYP1A1 genotypes and haplotypes and risk of oral cancer: a case-control study in South Indians. Genet Mol Biol. 2012;35(2):407–12.PubMedCentralPubMedCrossRef
9.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.PubMedCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.PubMedCrossRef
10.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.PubMedCrossRef
11.
go back to reference Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.PubMedCrossRef Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.PubMedCrossRef
12.
go back to reference Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49:1–6.PubMedCrossRef Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49:1–6.PubMedCrossRef
13.
14.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
15.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
16.
go back to reference Egger M, Davey Smith G, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34. Egger M, Davey Smith G, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34.
17.
go back to reference Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, et al. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37:593–8.PubMedCrossRef Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, et al. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37:593–8.PubMedCrossRef
18.
go back to reference Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, et al. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med. 2002;31:505–11.PubMedCrossRef Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, et al. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med. 2002;31:505–11.PubMedCrossRef
19.
go back to reference Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9:62–7.PubMedCrossRef Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9:62–7.PubMedCrossRef
20.
go back to reference Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28:819–26.PubMedCrossRef Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28:819–26.PubMedCrossRef
21.
go back to reference Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28:1455–62.PubMedCrossRef Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28:1455–62.PubMedCrossRef
22.
go back to reference Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48:233–9.PubMedCentralPubMedCrossRef Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48:233–9.PubMedCentralPubMedCrossRef
23.
go back to reference Losi-Guembarovski R, Colus IM, De Menezes RP, Poliseli F, Chaves VN, et al. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res. 2008;28:1023–8.PubMed Losi-Guembarovski R, Colus IM, De Menezes RP, Poliseli F, Chaves VN, et al. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res. 2008;28:1023–8.PubMed
24.
go back to reference Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, et al. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oral Lett. 2010;1:549–33. Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, et al. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oral Lett. 2010;1:549–33.
25.
go back to reference Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, et al. Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic predispositions of oral cancers and other oral pathologies: tobacco and alcohol as risk modifiers. Indian J Clin Biochem. 2010;25:260–72.PubMedCentralPubMedCrossRef Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, et al. Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic predispositions of oral cancers and other oral pathologies: tobacco and alcohol as risk modifiers. Indian J Clin Biochem. 2010;25:260–72.PubMedCentralPubMedCrossRef
26.
go back to reference Deepika S, Alka Dinesh K, Seema H, Subbiah V, Yerrmalla V. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Rap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):253–9.CrossRef Deepika S, Alka Dinesh K, Seema H, Subbiah V, Yerrmalla V. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Rap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):253–9.CrossRef
27.
go back to reference Guo L, Zhang C, Shi S, Guo X. Correlation between smoking and the polymorphisms of cytochrome P450 1A1-Msp I and glutathione S-trans-ferase T1 genes and oral cancer. West China J Stomatology. 2012;2:30. Guo L, Zhang C, Shi S, Guo X. Correlation between smoking and the polymorphisms of cytochrome P450 1A1-Msp I and glutathione S-trans-ferase T1 genes and oral cancer. West China J Stomatology. 2012;2:30.
28.
go back to reference Singh RD, Haridas N, Shah FD, Patel JB, Shukla SN, et al. Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat. West India Oral Dis. 2014;20:84–93.CrossRef Singh RD, Haridas N, Shah FD, Patel JB, Shukla SN, et al. Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat. West India Oral Dis. 2014;20:84–93.CrossRef
30.
go back to reference Chen Z, Li Z, Niu X, Ye X, Yu Y, et al. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis. 2011;26:437–46.PubMedCrossRef Chen Z, Li Z, Niu X, Ye X, Yu Y, et al. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis. 2011;26:437–46.PubMedCrossRef
31.
go back to reference Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:459–69.PubMedCrossRef Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:459–69.PubMedCrossRef
32.
go back to reference Shaik AP, Jamil K, Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J. 2009;6:78–86.PubMed Shaik AP, Jamil K, Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J. 2009;6:78–86.PubMed
33.
go back to reference Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.PubMedCentralPubMedCrossRef Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.PubMedCentralPubMedCrossRef
34.
go back to reference Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol. 2008;32:945–73.PubMed Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol. 2008;32:945–73.PubMed
35.
go back to reference Devasena A, Amelie C, Valerie G, Silvia F, Rolando H, et al. Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. PLOS ONE. 2014;9(2):e88240.CrossRef Devasena A, Amelie C, Valerie G, Silvia F, Rolando H, et al. Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. PLOS ONE. 2014;9(2):e88240.CrossRef
36.
go back to reference Zhuo X, Zhao H, Chang A, Zhou Y, et al. Quantitative Assessment of CYP1A1*2A variation with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls. Cancer Investig. 2012;30:552–9.CrossRef Zhuo X, Zhao H, Chang A, Zhou Y, et al. Quantitative Assessment of CYP1A1*2A variation with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls. Cancer Investig. 2012;30:552–9.CrossRef
37.
go back to reference Wacholder S, Silverman DT, Mclaughlin JK, Mandel JS. Selection of controls in case-control studies II. Types of controls. Am J Epidemiol. 1992;135:1029–41.PubMed Wacholder S, Silverman DT, Mclaughlin JK, Mandel JS. Selection of controls in case-control studies II. Types of controls. Am J Epidemiol. 1992;135:1029–41.PubMed
Metadata
Title
CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies
Authors
Kai-Tao Yu
Cheng Ge
Xiao-Fang Xu
Jing-Cai Zou
Xuan Zou
Shuai Zhen
Publication date
01-11-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 11/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2422-y

Other articles of this Issue 11/2014

Tumor Biology 11/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine